The therapy, created by the AIM Institute of Medicine under Dr. Toru Miyazaki, targets chronic kidney disease, a leading cause of death in older cats. It uses a specialized protein to help macrophages clear waste from the kidneys, partially restoring their function and slowing kidney failure.